首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Clinical efficacy of MVD combined with PSR in the treatment of primary trigeminal neuralgia
【2h】

Clinical efficacy of MVD combined with PSR in the treatment of primary trigeminal neuralgia

机译:MVD与PSR联合PSR治疗原发性三叉神经痛的临床疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clinical efficacy of microvascular decompression (MVD) combined with percutaneous stereotactic radiofrequency rhizotomy (PSR) in the treatment of primary trigeminal neuralgia was investigated. The medical records of 141 patients with primary trigeminal neuralgia admitted to Shandong Provincial Hospital from May 2011 to June 2013 were collected. Among them, 63 patients received MVD surgery and were set as group A, while the other 78 received MVD combined with PSR and were as group B. The efficacy and complication of the two treatment methods were compared. Multivariate logistic regression was performed to analyze the risk factors for treatment efficacy. The total effective rate was 96.15% in group B, higher than that in group A (88.89%), but the difference was not statistically significant (P>0.05). The complications in group B were statistically less than that in group A (P<0.05). Risk factors for the onset of primary trigeminal neuralgia included the degree of decompression, duration of disease, degree of compression, and clinical symptoms. Patients treated with MVD combined with PSR had a better quality of life and lower 5-year recurrence rate than patients treated with MVD (both P<0.05). In conclusion, MVD combined with PSR treatment has good clinical efficacy in primary trigeminal neuralgia and low incidence of complications. The possible risk factors for the onset of primary trigeminal neuralgia include the degree of decompression, duration of disease, degree of compression, and clinical symptoms.
机译:研究了微血管减压(MVD)与经皮立体定向射出射出术(PSR)治疗原发性三叉神经痛的临床疗效。收集了2011年5月至2013年5月从2011年5月到2013年5月录取山东省医院141名患有141名患有141名患有141名患有141名患有141名患者。其中,63名患者接受了MVD手术,并被设定为A组,而另一个78接受MVD与PSR联合,并作为B组。比较了两种治疗方法的疗效和并发症。进行多元逻辑回归,以分析治疗效能的危险因素。 B组的总有效率为96.15%,高于A组(88.89%),但差异没有统计学意义(P> 0.05)。 B组的并发症在统计学上少于A组(P <0.05)。原发性三叉神经痛发作的危险因素包括减压程度,疾病持续时间,压缩程度和临床症状。用MVD治疗的患者联合PSR具有更好的生活质量和比用MVD处理的患者更高的寿命和降低的5年复发率(P <0.05)。总之,MVD与PSR治疗相结合,在原发性三叉神经痛中具有良好的临床疗效,并且并发症发病率低。发起初生三叉神经痛的可能危险因素包括减压程度,疾病持续时间,压缩程度和临床症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号